226 related articles for article (PubMed ID: 24490114)
1. Emerging candidate biomarkers for Parkinson's disease: a review.
Saracchi E; Fermi S; Brighina L
Aging Dis; 2014 Feb; 5(1):27-34. PubMed ID: 24490114
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers in Parkinson's disease: Advances and strategies.
Delenclos M; Jones DR; McLean PJ; Uitti RJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S106-10. PubMed ID: 26439946
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers in Parkinson's disease (recent update).
Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
[TBL] [Abstract][Full Text] [Related]
4. Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.
Mollenhauer B; Parnetti L; Rektorova I; Kramberger MG; Pikkarainen M; Schulz-Schaeffer WJ; Aarsland D; Svenningsson P; Farotti L; Verbeek MM; Schlossmacher MG
J Neurochem; 2016 Oct; 139 Suppl 1():290-317. PubMed ID: 26452984
[TBL] [Abstract][Full Text] [Related]
5. What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?
Kim D; Paik JH; Shin DW; Kim HS; Park CS; Kang JH
Exp Neurobiol; 2014 Dec; 23(4):352-64. PubMed ID: 25548535
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson's Disease.
Kang JH
J Mov Disord; 2016 May; 9(2):89-96. PubMed ID: 27240810
[TBL] [Abstract][Full Text] [Related]
7. Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?
Le W; Dong J; Li S; Korczyn AD
Neurosci Bull; 2017 Oct; 33(5):535-542. PubMed ID: 28866850
[TBL] [Abstract][Full Text] [Related]
8. Alpha-Synuclein as a Biomarker for Parkinson's Disease.
Atik A; Stewart T; Zhang J
Brain Pathol; 2016 May; 26(3):410-8. PubMed ID: 26940058
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for the diagnosis and management of Parkinson's disease.
Waragai M; Sekiyama K; Fujita M; Tokuda T; Hashimoto M
Expert Opin Med Diagn; 2013 Jan; 7(1):71-83. PubMed ID: 23530844
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic markers for Parkinson's disease.
Chahine LM; Stern MB
Curr Opin Neurol; 2011 Aug; 24(4):309-17. PubMed ID: 21464716
[TBL] [Abstract][Full Text] [Related]
11. Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.
Eidson LN; Kannarkat GT; Barnum CJ; Chang J; Chung J; Caspell-Garcia C; Taylor P; Mollenhauer B; Schlossmacher MG; Ereshefsky L; Yen M; Kopil C; Frasier M; Marek K; Hertzberg VS; Tansey MG
J Neuroinflammation; 2017 Aug; 14(1):164. PubMed ID: 28821274
[TBL] [Abstract][Full Text] [Related]
12. Disease modification in Parkinson's disease.
Henchcliffe C; Severt WL
Drugs Aging; 2011 Aug; 28(8):605-15. PubMed ID: 21812497
[TBL] [Abstract][Full Text] [Related]
13. The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer's Disease and Parkinson's Disease.
Pawlik P; Błochowiak K
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33671562
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's Diseases.
Parnetti L; Eusebi P; Lleó A
Front Neurol Neurosci; 2016; 39():117-23. PubMed ID: 27463974
[TBL] [Abstract][Full Text] [Related]
15. Current Challenges Towards the Development of a Blood Test for Parkinson's Disease.
Santiago JA; Potashkin JA
Diagnostics (Basel); 2014 Oct; 4(4):153-64. PubMed ID: 26852683
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for Parkinson's Disease: How Good Are They?
Li T; Le W
Neurosci Bull; 2020 Feb; 36(2):183-194. PubMed ID: 31646434
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression.
Marek K; Jennings D; Tamagnan G; Seibyl J
Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587
[TBL] [Abstract][Full Text] [Related]
18. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease.
Hong Z; Shi M; Chung KA; Quinn JF; Peskind ER; Galasko D; Jankovic J; Zabetian CP; Leverenz JB; Baird G; Montine TJ; Hancock AM; Hwang H; Pan C; Bradner J; Kang UJ; Jensen PH; Zhang J
Brain; 2010 Mar; 133(Pt 3):713-26. PubMed ID: 20157014
[TBL] [Abstract][Full Text] [Related]
19. The Concept of Prodromal Parkinson's Disease.
Mahlknecht P; Seppi K; Poewe W
J Parkinsons Dis; 2015; 5(4):681-97. PubMed ID: 26485429
[TBL] [Abstract][Full Text] [Related]
20. Premotor biomarkers for Parkinson's disease - a promising direction of research.
Haas BR; Stewart TH; Zhang J
Transl Neurodegener; 2012 May; 1(1):11. PubMed ID: 23211054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
